Phenotypic and epigenetic heterogeneity in FGFR2 ‐fused glial and glioneuronal tumours
Neuropathology and Applied Neurobiology · 2024
DOI: 10.1111/nan.13014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, 2024. Verfasst von Alice Métais und 29 weiteren Autor:innen. Beteiligte Einrichtung: Service de Neuropathologie, GHU Paris Psychiatrie et Neurosciences, Paris, France. Hauptthemen laut MEDLINE: Brain Neoplasms, Receptor, Fibroblast Growth Factor, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institut National Du Cancer, Association Cassandra, ARTC-sud.
Abstract (Originalsprache)
Aims
FGFR ‐fused central nervous system (CNS) tumours are rare and are usually within the glioneuronal and neuronal tumours or the paediatric‐type diffuse low‐grade glioma spectrum. Among this spectrum, FGFR2 fusion has been documented in tumours classified by DNA‐methylation profiling as polymorphous low‐grade neuroepithelial tumours of the young (PLNTY), a recently described tumour type. However, FGFR2 fusions have also been reported in glioneuronal tumours, highlighting the overlapping diagnostic criteria and challenges.
Methods
We investigated the FGFR2 fusion landscape in a French national series of tumours sent to the RENOCLIP‐LOC network. We comprehensively analysed histology, radiology and molecular data including DNA‐methylation profiling for 16 FGFR2 ‐fused glioneuronal tumours.
Results
Most tumours were located in the temporal or parietal lobe with a median age at diagnosis of 7 years [1–44]. Epilepsy was the most frequent symptom. Five patients had tumour progression or recurrence with a median progression‐free survival of 22.6 months. Histological phenotypes corresponding to PLNTY, GG, MVNT or unclassified tumours were recorded. Epigenetic profiling could not properly distinguish epigenetic clusters related to the GG and PLNTY methylation classes among FGFR2 ‐fused glioneuronal tumours. However, a neuroradiological review identified strikingly distinct neuroradiological patterns.
Conclusion
While delineating tumour types among the FGFR2 ‐fused glioneuronal tumour spectrum, by histopathology or DNA‐methylation profiling, remains challenging, neuroimaging data revealed two distinct patterns that could correlate to PLNTY and ganglioglioma. However, more series including extensive histo‐radio‐molecular data are needed to confirm this hypothesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Neuropathologie, GHU Paris Psychiatrie et Neurosciences, Paris, France.
- Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Paris, France.
- Paediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université Paris cité, Paris, France.
- Institut Imagine INSERM U1163 and U1299, Paris, France.
- APHM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
- Neuroradiology Department, Lille University, Medical Centre, Lille, France.
ORCID-Profile: Alice Métais, Volodia Dangouloff-Ros, Dominique Figarella-Branger
Förderung
- Institut National Du Cancer
- Association Cassandra
- ARTC-sud
- Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent
- Liv & Lumière
- Canceropôle PACA
- Fédération Enfants Cancers Santé
- GIRCI Méditerranée
Zitieren
APA
Métais, A., Dangouloff-Ros, V., Garcia, J., Vannod-Michel, Q., Csanyi, M., Tauziède-Espariat, A., Appay, R., Maurage, C. A., Uro-Coste, E., Meyronet, D., Rigau, V., Rousseau, A., Chotard, G., Hamelin, J., Pierron, G., Colin, C., Ollivier, M., Roques, M., Provost, C., …, & of the Neuroradiological RENOCLIP‐LOC network (2024). Phenotypic and epigenetic heterogeneity in FGFR2 ‐fused glial and glioneuronal tumours. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.13014
Vancouver
Métais A, Dangouloff-Ros V, Garcia J, Vannod-Michel Q, Csanyi M, Tauziède-Espariat A, et al. Phenotypic and epigenetic heterogeneity in FGFR2 ‐fused glial and glioneuronal tumours. Neuropathology and Applied Neurobiology. 2024. doi:10.1111/nan.13014
BibTeX
@article{Mtais2024,
author = {Métais, Alice and Dangouloff-Ros, Volodia and Garcia, Jeremy and Vannod-Michel, Quentin and Csanyi, Marie and Tauziède-Espariat, Arnault and Appay, Romain and Maurage, Claude-Alain and Uro-Coste, Emmanuelle and Meyronet, David and Rigau, Valérie and Rousseau, Audrey and Chotard, Guillaume and Hamelin, Jocelyne and Pierron, Gaelle and Colin, Carole and Ollivier, Morgan and Roques, Margaux and Provost, Corentin and Cottier, Jean-Philippe and Pallud, Johan and Chrétien, Fabrice and Guida, Lelio and Blauwblomme, Thomas and Boddaert, Nathalie and Varlet, Pascale and Edjlali, Myriam and Figarella-Branger, Dominique and contributors of the Biopathology RENOCLIP‐LOC network, contributors of the Biopathology RENOCLIP‐LOC network and of the Neuroradiological RENOCLIP‐LOC network, of the Neuroradiological RENOCLIP‐LOC network},
title = {Phenotypic and epigenetic heterogeneity in FGFR2 ‐fused glial and glioneuronal tumours},
journal = {Neuropathology and Applied Neurobiology},
year = {2024},
doi = {10.1111/nan.13014}
}
EUVIMED